An evidence based hypothesis on the existence of two pathways of mitochondrial crista formation

  1. Max E Harner  Is a corresponding author
  2. Ann-Katrin Unger
  3. Willie JC Geerts
  4. Muriel Mari
  5. Toshiaki Izawa
  6. Maria Stenger
  7. Stefan Geimer
  8. Fulvio Reggiori
  9. Benedikt Westermann
  10. Walter Neupert  Is a corresponding author
  1. Max Planck Institute of Biochemistry, Germany
  2. Universität Bayreuth, Germany
  3. Universiteit Utrecht, Netherlands
  4. University of Groningen, Netherlands

Abstract

Metabolic function and architecture of mitochondria are intimately linked. More than 60 years ago, cristae were discovered as characteristic elements of mitochondria that harbor the protein complexes of oxidative phosphorylation, but how cristae are formed, remained an open question. Here we present experimental results obtained with yeast that support a novel hypothesis on the existence of two molecular pathways that lead to generation of lamellar and tubular cristae. Formation of lamellar cristae depends on the mitochondrial fusion machinery through a pathway that is required also for homeostasis of mitochondria and mitochondrial DNA. Tubular cristae are formed via invaginations of the inner boundary membrane by a pathway independent of the fusion machinery. Dimerization of the F1FO-ATP synthase and presence of the MICOS complex are necessary for both pathways. The proposed hypothesis is suggested to apply also to higher eukaryotes, since the key components are conserved in structure and function throughout evolution.

Article and author information

Author details

  1. Max E Harner

    Max Planck Institute of Biochemistry, Martinsried, Germany
    For correspondence
    max.harner@med.uni-muenchen.de
    Competing interests
    The authors declare that no competing interests exist.
  2. Ann-Katrin Unger

    Cell Biology and Electron Microscopy, Universität Bayreuth, Bayreuth, Germany
    Competing interests
    The authors declare that no competing interests exist.
  3. Willie JC Geerts

    Biomolecular Imaging, Bijvoet Center, Universiteit Utrecht, Utrecht, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  4. Muriel Mari

    Department of Cell Biology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  5. Toshiaki Izawa

    Max Planck Institute of Biochemistry, Martinsried, Germany
    Competing interests
    The authors declare that no competing interests exist.
  6. Maria Stenger

    Cell Biology and Electron Microscopy, Universität Bayreuth, Bayreuth, Germany
    Competing interests
    The authors declare that no competing interests exist.
  7. Stefan Geimer

    Cell Biology and Electron Microscopy, Universität Bayreuth, Bayreuth, Germany
    Competing interests
    The authors declare that no competing interests exist.
  8. Fulvio Reggiori

    Department of Cell Biology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  9. Benedikt Westermann

    Cell Biology and Electron Microscopy, Universität Bayreuth, Bayreuth, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2991-1604
  10. Walter Neupert

    Max Planck Institute of Biochemistry, Martinsried, Germany
    For correspondence
    Neupert@biochem.mpg.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0571-4419

Funding

Max-Planck-Gesellschaft

  • Max E Harner
  • Ann-Katrin Unger
  • Toshiaki Izawa
  • Walter Neupert

Carl Friedrich von Siemens Stiftung

  • Walter Neupert

Jung-Stiftung für Wissenschaft und Forschung

  • Max E Harner

Ludwig-Maximilians-Universität München

  • Max E Harner

Netherlands organization for Scientific Research (DN82-303)

  • Fulvio Reggiori

Deutsche Forschungsgemeinschaft (DN82-303)

  • Fulvio Reggiori

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (CRSII3_154421)

  • Fulvio Reggiori

ZonMw (ZonMW VICI)

  • Fulvio Reggiori

Netherlands organization for Scientific Research (822.02.014)

  • Fulvio Reggiori

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2016, Harner et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,712
    views
  • 946
    downloads
  • 78
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Max E Harner
  2. Ann-Katrin Unger
  3. Willie JC Geerts
  4. Muriel Mari
  5. Toshiaki Izawa
  6. Maria Stenger
  7. Stefan Geimer
  8. Fulvio Reggiori
  9. Benedikt Westermann
  10. Walter Neupert
(2016)
An evidence based hypothesis on the existence of two pathways of mitochondrial crista formation
eLife 5:e18853.
https://doi.org/10.7554/eLife.18853

Share this article

https://doi.org/10.7554/eLife.18853

Further reading

    1. Biochemistry and Chemical Biology
    Luca Unione, Jesús Jiménez-Barbero
    Insight

    Glycans play an important role in modulating the interactions between natural killer cells and antibodies to fight pathogens and harmful cells.

    1. Biochemistry and Chemical Biology
    2. Cell Biology
    Kristina Ehring, Sophia Friederike Ehlers ... Kay Grobe
    Research Article

    The Sonic hedgehog (Shh) signaling pathway controls embryonic development and tissue homeostasis after birth. This requires regulated solubilization of dual-lipidated, firmly plasma membrane-associated Shh precursors from producing cells. Although it is firmly established that the resistance-nodulation-division transporter Dispatched (Disp) drives this process, it is less clear how lipidated Shh solubilization from the plasma membrane is achieved. We have previously shown that Disp promotes proteolytic solubilization of Shh from its lipidated terminal peptide anchors. This process, termed shedding, converts tightly membrane-associated hydrophobic Shh precursors into delipidated soluble proteins. We show here that Disp-mediated Shh shedding is modulated by a serum factor that we identify as high-density lipoprotein (HDL). In addition to serving as a soluble sink for free membrane cholesterol, HDLs also accept the cholesterol-modified Shh peptide from Disp. The cholesteroylated Shh peptide is necessary and sufficient for Disp-mediated transfer because artificially cholesteroylated mCherry associates with HDL in a Disp-dependent manner, whereas an N-palmitoylated Shh variant lacking C-cholesterol does not. Disp-mediated Shh transfer to HDL is completed by proteolytic processing of the palmitoylated N-terminal membrane anchor. In contrast to dual-processed soluble Shh with moderate bioactivity, HDL-associated N-processed Shh is highly bioactive. We propose that the purpose of generating different soluble forms of Shh from the dual-lipidated precursor is to tune cellular responses in a tissue-type and time-specific manner.